Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study
- 1 November 1988
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 42 (6) , 363-368
- https://doi.org/10.1007/bf02556354
Abstract
Prostaglandin E2 (PGE2) at a dose of 10 mg/kg was administered orally to beagles used in a study of rib fracture and drill hole defect healing. Double fluochrome labels were given prior to surgical manipulation and before necropsy at 30 days. Bone remodeling was evaluated in trabecular bone of the fourth lumbar vertebra. There was a decrease in the number and extent of posttreatment labels (PPP2 for 30 days following surgery, the extent of posttreatment labels (PP2 for 5 days prior to surgical manipulation and between the first and second pretreatment labels, the extent of the double-labeled surface was increased (P2 given orally has a systemic effect on bone remodeling in vertebral trabeculae that involves the stimulation of formation activity.This publication has 31 references indexed in Scilit:
- The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2Bone, 1987
- Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: A histomorphometric studyBone, 1987
- Regional acceleration of remodeling during healing of bone defects in beagles of various agesBone, 1985
- Regulation of Bone FormationNew England Journal of Medicine, 1983
- Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart diseaseThe Journal of Pediatrics, 1980
- Prostaglandin as a Mediator of Bone Resorption Induced by Experimental Tooth Movement in RatsJournal of Dental Research, 1980
- Bone remodeling in chronic renal failure in perinatally irradiated beaglesCalcified Tissue International, 1977
- Effects of Prostaglandin E1 on the Periodontium of RatsJournal of Dental Research, 1977
- Prostaglandin in Calcium and Bone MetabolismPublished by Wolters Kluwer Health ,1975
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972